Natixis Advisors, L.P.
- SEC CIK
- 0001018331
- Latest filing
- Aug 14, 2026
PCVX holding history
Vaxcyte, Inc. in every 13F filed by Natixis Advisors, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PCVX overviewAll 13F holders of PCVXFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −14,649−100.0% | Sold out | Holders |
| Q1 2025 | 14,649 | $553.0K | <0.1% | −888−5.7% | Reduced | Holders |
| Q4 2024 | 15,537 | $1.27M | <0.1% | −7,160−31.5% | Reduced | Holders |
| Q3 2024 | 22,697 | $2.59M | <0.1% | +8,606+61.1% | Added | Holders |
| Q2 2024 | 14,091 | $1.06M | <0.1% | +861+6.5% | Added | Holders |
| Q1 2024 | 13,230 | $904.0K | <0.1% | −805−5.7% | Reduced | Holders |
| Q4 2023 | 14,035 | $881.0K | <0.1% | +14,035 | New | Holders |